Lisa Gill
Stock Analyst at JP Morgan
(2.98)
# 1,291
Out of 5,169 analysts
141
Total ratings
42.11%
Success rate
0.14%
Average return
Main Sectors:
Stocks Rated by Lisa Gill
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Neutral | $9 → $7 | $5.42 | +29.15% | 10 | Mar 13, 2026 | |
| MDLN Medline | Maintains: Overweight | $50 → $53 | $42.26 | +25.41% | 2 | Mar 10, 2026 | |
| GDRX GoodRx Holdings | Downgrades: Neutral | n/a | $2.17 | - | 3 | Feb 27, 2026 | |
| LH Labcorp Holdings | Maintains: Overweight | $319 → $330 | $265.84 | +24.13% | 4 | Feb 18, 2026 | |
| CAH Cardinal Health | Maintains: Neutral | $209 → $243 | $211.87 | +14.69% | 7 | Feb 10, 2026 | |
| COR Cencora | Maintains: Overweight | $417 → $419 | $325.18 | +28.85% | 4 | Feb 10, 2026 | |
| MCK McKesson | Maintains: Overweight | $983 → $1,107 | $920.35 | +20.28% | 15 | Feb 10, 2026 | |
| ELV Elevance Health | Maintains: Overweight | $394 → $397 | $294.95 | +34.60% | 7 | Feb 2, 2026 | |
| UNH UnitedHealth Group | Maintains: Overweight | $425 → $389 | $284.33 | +36.81% | 11 | Feb 2, 2026 | |
| CVS CVS Health | Maintains: Overweight | $93 → $101 | $73.02 | +38.32% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $23 | $18.19 | +26.44% | 6 | Dec 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $32 → $33 | $21.59 | +52.85% | 6 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $25 → $26 | $17.87 | +45.50% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $428 → $375 | $264.61 | +41.72% | 14 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 → $10 | $6.91 | +44.72% | 3 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $190 | $195.23 | -2.68% | 3 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $29 → $30 | $22.80 | +31.58% | 2 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $40 → $41 | $29.66 | +38.23% | 4 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $257 → $256 | $170.42 | +50.22% | 6 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $18 | $34.80 | -48.28% | 2 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $5 | $8.24 | -39.32% | 4 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $28 | $12.36 | +126.54% | 4 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $9.03 | +99.34% | 1 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $395 | $148.63 | +165.76% | 2 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $182 → $186 | $189.58 | -1.89% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $107 → $140 | $203.21 | -31.11% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $327 → $332 | $502.05 | -33.87% | 3 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $17 → $9 | $0.59 | +1,425.17% | 3 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $8 | $6.41 | +24.80% | 4 | Nov 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $83 | $73.12 | +13.51% | 1 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $103 → $98 | $36.16 | +171.02% | 1 | Jan 6, 2023 |
Teladoc Health
Mar 13, 2026
Maintains: Neutral
Price Target: $9 → $7
Current: $5.42
Upside: +29.15%
Medline
Mar 10, 2026
Maintains: Overweight
Price Target: $50 → $53
Current: $42.26
Upside: +25.41%
GoodRx Holdings
Feb 27, 2026
Downgrades: Neutral
Price Target: n/a
Current: $2.17
Upside: -
Labcorp Holdings
Feb 18, 2026
Maintains: Overweight
Price Target: $319 → $330
Current: $265.84
Upside: +24.13%
Cardinal Health
Feb 10, 2026
Maintains: Neutral
Price Target: $209 → $243
Current: $211.87
Upside: +14.69%
Cencora
Feb 10, 2026
Maintains: Overweight
Price Target: $417 → $419
Current: $325.18
Upside: +28.85%
McKesson
Feb 10, 2026
Maintains: Overweight
Price Target: $983 → $1,107
Current: $920.35
Upside: +20.28%
Elevance Health
Feb 2, 2026
Maintains: Overweight
Price Target: $394 → $397
Current: $294.95
Upside: +34.60%
UnitedHealth Group
Feb 2, 2026
Maintains: Overweight
Price Target: $425 → $389
Current: $284.33
Upside: +36.81%
CVS Health
Dec 17, 2025
Maintains: Overweight
Price Target: $93 → $101
Current: $73.02
Upside: +38.32%
Dec 17, 2025
Maintains: Overweight
Price Target: $20 → $23
Current: $18.19
Upside: +26.44%
Nov 13, 2025
Maintains: Overweight
Price Target: $32 → $33
Current: $21.59
Upside: +52.85%
Nov 11, 2025
Maintains: Neutral
Price Target: $25 → $26
Current: $17.87
Upside: +45.50%
Nov 4, 2025
Maintains: Overweight
Price Target: $428 → $375
Current: $264.61
Upside: +41.72%
Sep 18, 2025
Upgrades: Neutral
Price Target: $6 → $10
Current: $6.91
Upside: +44.72%
May 6, 2025
Maintains: Neutral
Price Target: $180 → $190
Current: $195.23
Upside: -2.68%
Mar 19, 2025
Maintains: Overweight
Price Target: $29 → $30
Current: $22.80
Upside: +31.58%
Mar 6, 2025
Maintains: Overweight
Price Target: $40 → $41
Current: $29.66
Upside: +38.23%
Feb 18, 2025
Maintains: Neutral
Price Target: $257 → $256
Current: $170.42
Upside: +50.22%
Dec 17, 2024
Downgrades: Neutral
Price Target: $18
Current: $34.80
Upside: -48.28%
Dec 17, 2024
Downgrades: Underweight
Price Target: $5
Current: $8.24
Upside: -39.32%
Dec 3, 2024
Maintains: Neutral
Price Target: $38 → $28
Current: $12.36
Upside: +126.54%
Aug 12, 2024
Initiates: Neutral
Price Target: $18
Current: $9.03
Upside: +99.34%
Jul 10, 2024
Maintains: Overweight
Price Target: $420 → $395
Current: $148.63
Upside: +165.76%
May 30, 2024
Maintains: Neutral
Price Target: $182 → $186
Current: $189.58
Upside: -1.89%
May 30, 2024
Maintains: Overweight
Price Target: $107 → $140
Current: $203.21
Upside: -31.11%
May 30, 2024
Maintains: Neutral
Price Target: $327 → $332
Current: $502.05
Upside: -33.87%
Jan 5, 2024
Downgrades: Neutral
Price Target: $17 → $9
Current: $0.59
Upside: +1,425.17%
Nov 17, 2023
Maintains: Neutral
Price Target: $10 → $8
Current: $6.41
Upside: +24.80%
Aug 9, 2023
Maintains: Neutral
Price Target: $80 → $83
Current: $73.12
Upside: +13.51%
Jan 6, 2023
Maintains: Overweight
Price Target: $103 → $98
Current: $36.16
Upside: +171.02%